Indicators on INCB3344 You Should Know
With this study we examined the activity of cefepime/zidebactam (WCK 5222) in opposition to consecutive reference laboratory submissions of Gram-destructive bacteria, taken like a sample of problem strains circulating in the UK.The steadiness of cefepime in opposition to AmpC, when coupled with an ESBL-Lively BLI, presents the protection of AmpC an